trial fibrillation (AF) is the most frequent arrhythmia observed in patients with an implanted pacemaker, and there are multiple factors for its etiology. [1] [2] [3] It has been shown that atrial pacing may have a preventive effect on AF recurrence. The antiarrhythmic effect of atrial pacing is not always immediate, but can be progressive in some patients, 4 and some pacing algorithms may also be useful. 5 Intra-and interatrial conduction disturbances are well-known factors predisposing to AF development and/or maintenance. Thus, the choice of atrial pacing site may play an important role in providing atrial electrical activation synchrony and diminishing the influence of abnormal atrial conduction on the incidence of AF. Some investigators have suggested that multisite atrial pacing (MAP), which incorporates 1 electrode in the right atrial appendage (RAA) and the other in the coronary sinus (CS) ostium area (dualsite atrial pacing) or in the mid-or distal CS (bi-atrial pacing), might be more beneficial than conventional RAA pacing. [6] [7] [8] Recently, our group proposed a novel method of MAP incorporating the Bachmann's bundle (BB) and CS ostium region. 9 This novel pacing modality presumes "double electrical resynchronization" of the left atrium (LA) and its antiarrhythmic effect has been shown in patients with AF. 9 However, up till now neither the optimal atrial pacing site nor the superiority of multisite over single-site atrial pacing has been ultimately determined.
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The aim of the study was to compare the hemodynamic effects of 2 MAP modalities and to determine the influence of the RA pacing lead positioning in the BB region compared with the typical RAA site on atrial contraction synchrony. It is presumed that beneficial hemodynamic effect of MAP would support its antiarrhythmic effect.
Methods

Patient Population
We studied 62 consecutive patients in whom MAP was conducted because of (1) sinus node dysfunction with class I or II indications for permanent cardiac pacing; (2) documented symptomatic AF recurrence (paroxysmal or persistent); (3) signs of advanced intra-and interatrial conduction delay: sinus P-wave duration ≥120 ms on the surface ECG; (4) no evidence of 2 nd or 3 rd degree atrioventricular (AV) block; and (5) no history of an ablation procedure. Patients were excluded if they had (1) moderately or severely depressed global left ventricular (LV) systolic function (1 patient); (2) moderate or severe valve disease or LV hypertrophy (1 patient); or (3) documented AF within 1 month preceding the examination (3 patients).
All patients were implanted with a standard dualchamber pacemaker (Axios DR, Philos DR, or Logos DS Biotronik GmbH & Co, Berlin, Germany). One atrial lead was connected to the atrial (A) port and the other to the ventricular (V) port. The atrial lead connected to the A-port was placed in the RAA (RAA+CS group) or the BB region (BB+CS group). In all patients the atrial lead connected to the V-port was implanted in the CS ostium area.
The implantation procedure was described previously. 9,10 Briefly, in patients from the BB+CS group the atrial lead was first placed in the RAA, which served as the reference position before it was moved to the BB area. The target region to implant the BB lead was the confluence of the RA roof and the interatrial septum (IAS). Implantation of the BB lead was based on the following criteria: (1) fluoroscopic position in the anteroposterior (AP) and lateral oblique view (LAO 60°); (2) AP view: minimal, only "up-and-down" movements of the lead tip were accepted; and (3) paced P-wave positive in leads I, II, III, starting immediately with the pacing spike. In the RAA+CS group, the RAA lead was placed normally. In both groups the 2 nd atrial lead was implanted in the proximity of the CS ostium. Ostial CS pacing was confirmed on the ECG by negative P-waves in the inferior limb leads. The chest X-ray films demonstrating the pacing lead positions in the BB region and the CS ostium area are presented in Figure 1 . After implantation, the pacemaker was programmed to a DDD mode, or DDDR in patients with chronotropic incompetence. The interatrial delay during MAP (AA delay) was set to 15 ms (the stimulus in the CS delayed by 15 ms with regard to RAA or BB area, respectively).
The study protocol was approved by the local ethical committee and all patients gave their written informed consent to both MAP and participation in the study.
Echocardiography
Echocardiographic studies were performed at least 1 year after pacemaker implantation, using a commercially available instrument (Vivid 7, GE Healthcare, Horten, Norway) with a 3.4-MHz phased array transducer. The basic pacing rate was programmed to exceed the intrinsic rate by at least 10 beats/min and was constant during the study. One echocardiographer, blind to the pacing mode, performed all data acquisitions and measurements. All analyses were performed off-line on an EchoPac workstation (GE, version 2.0.6) with a sweep of 100 mm/s. Parameters obtained from at least 3 consecutive beats were measured and the average was calculated.
Mitral and tricuspid inflow was recorded with pulsedwave Doppler at the level of the tips of the mitral (m) and tricuspid (t) leaflets during apnea. The following parameters were registered: diastolic filling time (DFT) and the diastolic velocity time integral (VTI), atrial wave duration (Adur), atrial VTI, and the time interval from the beginning of the pacing spike on the ECG to the beginning of the atrial wave (PA). In order to estimate cardiac output the aortic VTI was recorded with continuous-wave Doppler. At the level of the pulmonary veins (p), systolic and diastolic VTIs, as well as the Adur (Adurp) were registered.
The following parameters were calculated: (1) percentage of Adur in relation to the total DFT (%A), (2) mechanical AV delay in the right and left heart defined as the time between the beginning of the mitral/tricuspid atrial wave and the beginning of the aortic/pulmonary outflow spectrum (AV-RV/AV-LV), (3) myocardial performance index (MPI) defined as the ratio of the sum of the isovolumetric contraction and relaxation time divided by the LV ejection time, 11 (4) atrial contraction sequence defined as the time difference between the PAm and PAt interval: PA(m-t) = PAm − PAt, (5) the absolute value of PA(m-t), and (6) the difference between Adur at the level of the mitral and pulmonary veins (Adifm-p = Adurm − Adurp).
To compare the influence of MAP modalities on the atrial electromechanical delay (EMD) the pulsed-wave tissue Doppler recordings in several atrial sites were registered (Figure 2) . A 6-mm-wide sample volume was placed in the middle segment of the lateral LA and RA walls, and in the IAS just above the oval fossa in the apical 4-chamber view, and in the middle of the anterior and inferior LA walls in the apical 2-chamber view. The spectral pulsed-wave Doppler signal filters were adjusted until a Nyquist limit of 15- 20 cm/s, and a minimal optimal gain was used. Every effort was made to align the pulsed-wave cursor as parallel as possible to the direction of the particular atrial wall. The time distances were measured from the beginning of the P-wave or atrial pacing spike on the ECG until the beginning of the pulsed-wave tissue Doppler A'-wave in the LA lateral (p-LW), inferior (p-IW), anterior (p-AW), RA lateral (p-RA) walls and in the IAS (p-IAS). The following parameters of atrial contraction synchrony were calculated: (1) intra-LA dyssynchrony (∆-LA) defined as the maximal time difference among p-LW, p-IW, p-AW and p-IAS, (2) intra-RA dyssynchrony (∆-RA) defined as the absolute value of time difference between p-RA and p-IAS, and (3) interatrial dyssynchrony (∆-interA) defined as the absolute value of time difference between p-LW and p-RA.
Electrocardiographic Measurements P-wave duration and PR/stimulus-R interval were measured manually in lead II during sinus rhythm (SR) and MAP. P-wave morphology during BB+CS and RAA+CS pacing is shown in Figure 3 . Registration was performed by an ICS 3000 programmer (Biotronik) with a paper speed of 100 mm/s and 2 mV/cm calibration.
Statistical Analysis
Data are presented as mean ± standard deviation or number and percentage of patients. For continuous variables with normal distribution, the Student's t-tests for independent samples was applied. If variables did not follow normal distribution, the Mann-Whitney U-test was used for comparisons of independent measurements. Differences between categorical variables were tested with the chi-square test. Statistica software (version 7.1, StatSoft, Inc) was used to calculate statistics. P<0.05 was considered statistically significant.
Results
The final study population consisted of 57 patients (67±9 Data are number and percentage of patients or mean±standard deviation and range. *P<0.001 P-SR vs P-BI in both groups NYHA, New York Heart Association; LA, left atrium; LVESd/LVEDd, left ventricular end-diastolic/end-systolic diameter; LVEF, left ventricular ejection fraction; P-SR, P-wave duration during sinus rhythm; P-BI, P-wave duration during multi-site atrial pacing; PR, PR interval during sinus rhythm; Stimulus-R, stimulus-R interval during multi-site atrial pacing; HR, pacing rate. Other abbreviations see in Table 1 . years; 24 males): 28 patients in the RAA+CS group and 29 in the BB+CS group. The patients had normal mean LV ejection fraction (61±8%) and LV end-diastolic diameter (48±6 mm), slightly enlarged LA (40±6 mm) and prolonged sinus P-wave on the surface ECG (141±15 ms). Both groups did not differ with respect to any demographic, clinical, echocardiographic, ECG features, time from implantation, pacemaker programming or pharmacological treatment (Tables 1,2 ). During MAP a significant shortening of the P-wave was observed in both groups (P<0.001 vs SR, no difference between groups). The stimulus-R interval did not change with pacing ( Table 2) . Echocardiographic examination was performed after a mean time of 2.3±0.5 years since implantation (no difference between groups). The percentage of atrial pacing since implantation until the echocardiographic study was 88±8% (no difference between groups). None of the patients presented with AF or other atrial arrhythmias during the examination. Echocardiographic parameters are summarized in Table 3 .
Global Cardiac Function
Cardiac output, MPI and mechanical AV delay did not differ between the 2 studied MAP modalities. No differences were observed with regard to mitral or tricuspid inflow parameters. Detailed assessment of the mitral and tricuspid atrial waves also revealed no differences between groups. Adequate visualization of pulmonary venous flow was obtained in 26 patients in the RA+CS group (93%) and in 25 in the BB+CS group (86%). The atrial pacing modality had no influence on diastolic function, as no differences were registered with regard to the diastolic or systolic VTI at the level of the pulmonary veins, their ratio or the difference between the duration of the atrial wave at the level of the mitral valve or the pulmonary veins. The Adurp was longer than Adurm in 4 patients (15%) in the RAA+CS group, and in 3 (12%) in the BB+CS group (P=0.7); however, significant prolongation of Adurp in relation to Adurm (≥20 ms) was observed in only 1 patient from each group.
Atrial Sequence of Activation and Contraction Synchrony
In the BB+CS group the LA contraction appeared earlier than in the RAA+CS group: PAm 154±24 ms and 170±21 ms, respectively; P<0.01 (Table 3) . It resulted in reversal of the typical right-left atrial contraction sequence, as indicated by the negative sign of PA(m-t); however, the absolute value of PA(m-t) did not differ between groups. Reversed atrial contraction sequence was recorded in 10 patients (36%) from the RAA+CS group, and 22 (76%) in the BB+CS group (P<0.004). Among the 4 patients from the RAA+CS group who had a longer Adurp than Adurm, only 1 had at the same time reversed atrial contraction sequence. In the BB+CS group it was observed in 2 of 3 patients. 42±13 ( Table 1 .
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The time sequence of local atrial activation during the 2 MAP modalities is presented in Table 4 . EMD did not differ between the groups except in the lateral LA wall (p-LW). At all the other atrial sites the BB+CS, in comparison with RAA+CS pacing, resulted in significantly shorter EMD.
LA contraction synchrony was significantly greater in the BB+CS group than in the RAA+CS group: ∆-LA was, respectively 20±10 ms (5-58 ms) and 28±13 ms (6-57 ms), P<0.001. In the BB+CS group the interatrial contraction synchrony was also borderline greater: ∆-IAD 14±9 ms (0-33 ms) and 20±13 ms (2-48 ms), P=0.08. Right atrial synchrony did not differ between groups: ∆-RA 13±12 ms (0-49 ms) and 15±9 ms (2-34 ms) in the BB+CS and RAA+ CS group, respectively (P=0.2).
Discussion
The novel MAP modality aimed at "double LA resynchronization", with 1 of the atrial electrodes inserted in the BB area instead of the conventional location in the RAA, leads to earlier LA contraction and greater atrial synchrony without changing global cardiac hemodynamics. To our knowledge no previous study has assessed cardiac hemodynamics and atrial contraction synchrony in such a big population treated with MAP. 6,12-14 Additionally, we report on the cardiac hemodynamics during the novel MAP modality, which according to the preliminary clinical data has a favorable influence on AF recurrence. 9 Our present data suggest that in patients referred for MAP the BB rather than the typical RAA site is recommended.
The study population was a typical group of patients treated with permanent cardiac pacing. They presented predominantly with arterial hypertension, and in the majority LV cardiac function and dimensions were normal. The only exceptional feature was the atrial conduction abnormalities, which manifested as prolonged P-wave duration on the surface ECG (the mean P-wave during SR ≥140 ms). The 2 study groups did not differ with regard to age, gender, concomitant diseases or pharmacological treatment.
Inserting 1 of the atrial leads in the BB area, instead of in the RAA, during MAP resulted in earlier LA activation. It led to reversal of the typical right-left atrial contraction sequence in the majority of patients from the BB+CS group, twice as often as in the RAA+CS group. However, the absolute value of the global interatrial delay did not differ between the groups. Physiologically, RA precedes LA contraction 12, [15] [16] [17] and according to Barletta et al who have studied atrial contraction sequence in 66 healthy subjects, the mean interatrial delay amounts to 17.7±2.8 ms (−40-60 ms); 15 however, occasionally a reversed atrial contraction sequence can be observed. So far, 2 groups of investigators have examined the atrial contraction sequence during MAP, and in all their patients 1 of the atrial leads was placed in the RAA. 12, 18 In the present study the absolute value of the interatrial delay in both groups was comparable to the one estimated by Kindermann et al. 12 Despite the reversed atrial contraction sequence in the majority of patients from the BB+CS group, cardiac output and MPI did not differ between the groups. In our previous study, also, the atrial pacing mode had no influence on the global cardiac function. 18 Cardiac output during MAP was comparable to single-site RAA or CS pacing (the last pacing modality resulted in the greatest reversal of atrial contraction sequence).
Comparison of Adur at the level of the pulmonary veins (Adurp) and the mitral valve (Adurm) revealed no difference between the groups. Physiologically, LA contraction leads to reversed flow in the pulmonary veins, because of the higher pressure in the LA than in the pulmonary veins during end-diastole. The degree of reversal (and Adurp) depends on the pressure within the LA before its contraction, and additionally, on the pressure induced by the contraction itself. According to Appleton et al prolongation of Adurp ≥20 ms in relation to Adurm indicates elevated LV end-diastolic pressure (>15 mmHg). 19 In our study population, Adurp was longer than Adurm in 15% of patients in the RAA+CS group and 12% in the BB+CS group. This phenomenon was significantly less common than the observed reversal of the atrial contraction sequence (36% and 76% patients in the RAA+CS and BB+CS group, respectively). Significant prolongation of Adurp (≥20 ms) was observed only in 1 patient in each group, which indicates that earlier LA contraction and a reversed atrial contraction sequence does not lead to increased LA pressure.
Tissue Doppler echocardiography supplied important information regarding atrial synchrony. Up till now only Matsumoto et al 13 have used this technique to compare the acute effects of RAA and MAP on the basis of strain Doppler imaging in the lateral LA wall, IAS and lateral RA wall. Those authors observed resynchronization of the atria during MAP. In our study we used pulsed-wave tissue Doppler echocardiography with velocity registration to determine the beginning of local atrial contraction, as this technique has very high temporal resolution and is repeatable. Moreover, we assessed the time of atrial contraction in the anterior and inferior LA walls. Such an approach enabled us to determine the LA, RA and interatrial synchrony. This evaluation was performed for the first time in patients undergoing MAP.
Our results indicate that the beginning of contraction in the lateral LA was comparable in both groups. However, implantation of the lead in the BB area resulted in earlier atrial contraction in all the other LA regions and conse- quently greater LA contraction synchrony in the BB+CS group, and borderline greater interatrial synchrony. As observed by Rein et al, 17 interatrial synchrony in healthy subjects amounts to 22±15 ms, thus similar to our RAA+CS patients. It was even shorter in the BB+CS group in our study (14±9 ms). The results of atrial synchrony obtained by tissue Doppler echocardiography support the assumptions of the novel pacing modality. Implanting the atrial lead in the BB area instead of the RAA provides more efficient atrial resynchronization during MAP. The MAP modality had no influence on global cardiac systolic or diastolic function. Cardiac output, MPI or S/D ratio at the level of the pulmonary veins did not differ between the groups. This can be explained by several mechanisms. According to Doi et al hemodynamic improvement obtained with bi-atrial pacing is related to the interatrial conduction delay. 20 Atrial conduction abnormalities were present in all our patients, although no differences between the groups were observed. Also, the paced P-wave duration did not differ between the groups, so both pacing modalities induced a similar degree of electrical resynchronization. Moreover, the beginning of ventricular activation was similar, as there was no difference in the stimulus-R interval between the groups. In addition, the mechanical AV delay (AV-LV and AV-RV) did not differ between the groups. Thus, both pacing modalities had a comparable influence on the interatrial conduction abnormalities and the onset of ventricular activation.
Conclusions
In patients treated with MAP, implanting 1 of the atrial leads in the BB area instead of the RAA has no influence on global cardiac hemodynamics, but results in earlier LA contraction, and reversal of the typical right-left atrial contraction sequence, as well as providing greater LA contraction synchrony.
